Piccinni C; Raschi E; Poluzzi E; Puccini A; Cars T; Wettermark B; Diemberger I; Boriani G; De Ponti F., Trends in antiarrhythmic drug use after marketing authorization of dronedarone: comparison between Emilia Romagna (Italy) and Sweden., «EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY», 2013, 69, pp. 715 - 720 [Scientific article]
C. Piccinni; E. Poluzzi; E. Raschi; B. Vitamia; A. Koci; F. De Ponti, Use and Perception of Phytoestrogens
in Postmenopausal Women: Result
of a Questionnaire-Based Survey, in: ABSTRACTS, Adis, «DRUG SAFETY», 2013, pp. 867 - 868 (atti di: 13th ISoP Annual Meeting: ‘‘The Renaissance of Pharmacovigilance’’, Pisa, 01-04/10/2014) [Poster]
Poluzzi E; Sangiorgi E; Piccinni C; Clo M, Aderenza alla terapia antidepressiva in Emilia-Romagna, in: Riassunti, «ISTISAN CONGRESSI», 2012, pp. 74 - 74 (atti di: XXI Seminario Nazionale La valutazione dell’uso e della sicurezza dei farmaci: esperienze in Italia, Roma, 10 dicembre 2012) [Abstract]
Motola D.; Piccinni C.; Biagi C.; Raschi E.; Marra A.; Marchesini G.; Poluzzi E., Cardiovascular, Ocular and Bone Adverse Reactions Associated with Thiazolidinediones: A Disproportionality Analysis of the US FDA Adverse Event Reporting System Database., «DRUG SAFETY», 2012, 35, pp. 315 - 323 [Scientific article]
Elisabetta Poluzzi; Emanuel Raschi; Carlo Piccinni; Fabrizio De Ponti, Data Mining Techniques in Pharmacovigilance: Analysis of the Publicly Accessible FDA Adverse Event Reporting System (AERS), in: Data Mining Applications in Engineering and Medicine, RIJEKA, InTech, 2012, pp. 265 - 302 [Chapter or essay]
Sacripanti C; Piccinni C; Poluzzi E; De Ponti F, Drug-related Progressive Multifocal Leukoencephalopathy (PML): datamining of FDA_AERS (Adverse Event Reporting System), in: ABSTRACTS, Wiley Blackewell, «PHARMACOEPIDEMIOLOGY AND DRUG SAFETY», 2012, 21, pp. 43 - 43 (atti di: 28th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Barcelona, August 23-26, 2012) [Abstract]
Piccinni C; Raschi E; Poluzzi E; Puccini A; Cars T; Wettermark B; Diemberger I; Boriani G; De Ponti F, Impact of dronedarone authorisation on antiarrhythmic utilisation: interrupted time series strategy on Italian and Swedish prescription databases, in: Abstracts, 2012, pp. 1 - 1 (atti di: XVI Seminario Nazionale Dottorandi e Assegnisti in Farmacologia ed affini, Rimini, 16-19 settembre 2012) [Abstract]
Piccinni C; Raschi E; Poluzzi E; Puccini A; Cars T; Wettermark B; Diemberger I; Boriani G; De Ponti F., Interrupted time series analysis on the impact of dronedarone authorisation on Italian and Swedish antiarrhythmic prescriptions, in: ABSTRACTS, Wiley Blackewell, «PHARMACOEPIDEMIOLOGY AND DRUG SAFETY», 2012, 21, pp. 290 - 291 (atti di: 28th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Barcelona, August 23-26, 2012) [Abstract]
Tarricone I; Piccinni C; Poluzzi E; Romagnoli G; Gallingani F; Piazza A; Berardi D; De Ponti F; Fioritti A; Donegani, La condivisione dei trattamenti farmacologici in psichiatria e la percezione degli effetti avversi ai farmaci antipisicotici da medico, paziente e familiare, in: Abstract, 2012, pp. 1 - 1 (atti di: Workshop “Il punto di vista del paziente sulle reazioni avverse ai farmaci”, Bologna, 1 dicembre 2012) [Abstract]
Piccinni C; Piazza A; Poluzzi E; Tarricone I; Koci A; Berardi D; Fioritti A; De Ponti F, Profili di utilizzo dei farmaci antipsicotici nei centri salute mentale della AUSL di Bologna: determinanti clinici e sociali, in: Riassunti, «ISTISAN CONGRESSI», 2012, pp. 69 - 69 (atti di: XXI Seminario Nazionale La valutazione dell’uso e della sicurezza dei farmaci: esperienze in Italia, Roma, 10 dicembre 2012) [Abstract]
Tarricone I; Piccinni C; Poluzzi E; Romagnoli G; Storbini V; Gallingani F; Piazza A; Berardi D; Fioritti A; Donegani I, Psychiatrists’ Use of Shared Decision Making in the Treatment of Psychosis: The “Farmaci and Famiglie” Project in Bologna, in: Abstracts, 2012, pp. 118 - 119 (atti di: EPA-EU GEI Conference ‘Closing in on the Envirome in Mental Health, Maastricht, 13-16/06/2012) [Abstract]
Roberto G; Piccinni C; Biagi C; Koci A; Motola D; Vaccheri A; Montanaro N; Poluzzi E., Triptans and serious cardiovascular events: possible safety signals from the FDA Adverse Event Reporting System database, in: ABSTRACTS, Wiley Blackewell, «PHARMACOEPIDEMIOLOGY AND DRUG SAFETY», 2012, pp. 290 - 290 (atti di: 8th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Barcelona, August 23-26, 2012) [Abstract]
Sacripanti C; Piccinni C; Puccini A; Poluzzi E; Montanaro N, Analyses of natalizumab prescriptions and discontinuations in multiple sclerosis patients of an Italian region, in: Abstract Book, 2011, pp. 73 - 73 (atti di: Better Public Health through Pharmacoepidemiology and Quality Use of Medicine, Antwerp, 30/11/2011 - 01/12/2011) [Abstract]
E. Raschi; E. Poluzzi, Apparato Gastroenterico, in: WALLER D.G. RENWICK A.G. HILLIER K., Farmacologia Medica ed Elementi di Terapia, III Edizione, MILANO, Elsevier, 2011, pp. 339 - 379 . Opera originale: Autore: Waller, Renwick, Hillier - Titolo: Medical Pharmacology and Therapeutics [Book contributions (translation)]
C. Piccinni; D. Motola; G. Marchesini Reggiani; E. Poluzzi, Assessing the association of pioglitazone use and bladder cancer
through drug adverse event reporting, «DIABETES CARE», 2011, 34, pp. 1369 - 1371 [Scientific article]
